Simpler technique for measuring oxidative susceptibility by heparin affinity column isolation of lipoproteins

Clinica Chimica Acta

Volumn 283, Issue 1-2, 1999, Pages 89-103

  Kaplan, Irma V ^a   Hobbs, Gregory A ^a   Levinson, Stanley S ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Arteriosclerosis; Coronary artery disease; Fibrinogen

Indexed keywords

ALKADIENE; APOLIPOPROTEIN B; HEPARIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; LIPID OXIDATION; OXIDATION; PRIORITY JOURNAL; PROTEIN ISOLATION;

APOLIPOPROTEINS B; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, AFFINITY; HEPARIN; HUMANS; LIPOPROTEINS; OXIDATION-REDUCTION; PLASMA; REPRODUCIBILITY OF RESULTS;

EID: 0032767487     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00039-X     Document Type: Article

References (26)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witzum J.L. Beyond cholesterol. Modifications of low density lipoproteins that increase its atherogenicity. N Engl Med. 320:1989;915-924.
2. Witzum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherosclerosis. J Clin Invest. 88:1991;1785-1792.
3. Parthasarathy S., Quinn M.T., Schenke D.C., Carew T.E., Steinberg D. Oxidative modification of beta-very low density lipoprotein. Arteriosclerosis. 9:1989;398-404.
4. Jialal I., Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem. 42:1996;498-506.
5. Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D. Malondialdehyde modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest. 95:1995;2611-2619.
6. Jialal I., Freeman D.A., Grundy S.M. Varying susceptibility of different low density lipoproteins to oxidative modification. Arteriosclerosis and Thrombosis. 11:1991;482-488.
7. Liu K., Cuddy T.E., Pierce G.N. Oxidative status of lipoproteins in coronary disease patients. Am Heart J. 123:1992;285-290.
8. Regnström J., Nilsson P., Tornvall C., Landou C., Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary arteriosclerosis in man. Lancet. 339:1992;1183-1186.
9. Cominacini L., Garbin U., Pastorino A.M., Davoli A., Campagnola M., De Santis A., Pasini C., Faccini G.B., Trevisan M.T., Lo Cascio V. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 99:1993;63-70.
10. Jialal I., Grundy S.M. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Research. 33:1992;899-906.
11. Hanna A., Feller D., Witiak D., Newman H. Inhibition of low density lipoprotein oxidation by thyronines and probucol. Biochem Pharmacol. 45:1993;753-762.
12. Fruebis J., Bird D., Pattison J., Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Research. 38:1997;2455-2464.
13. Regnström J., Ström K., Moldeus P., Nilsson J.A. Analysis of lipoprotein diene formation in human serum exposed to copper. Free Rad Res Comms. 19:1993;267-278.
14. Schnitzer E., Pinchuk I., Fainaru M., Schafer Z., Lichtenberg D. Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidative-resistance. Biochem Biophys Res Corn. 216:1995;854-861.
15. Agil A., Fuller C.J., Jialal I. Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation:demonstration of a possible fenton reaction. Clin Chem. 41:1995;220-225.
16. Benzten C.L., Acuff K.J., Marechal B., Rosenthal M.A., Volk M.E. Direct determination of lipoprotein cholesterol distributions with micro-scale affinity chromatography columns. Clin Chem. 28:1982;1451-1456.
17. Maciejko J.J., Levinson S.S., Markyvech L., Smith M. Evaluation of a new method for assaying apo A-I and apo B ILipoproteins by rate nephelometry. Clin Chem. 11:1987;2065-2069.
18. Buege J.A., Aust S.D. Microsomal:lipid peroxidation. Methods Enzymol. 52:1978;302-311.
19. Esterbauer H., Striegl G., PuhI H. Rotheneder, Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms. 6:1989;67-75.
20. Tschantz J.C., Sunahara G.I. Microaffinity chromatographic separation and characterization of lipoprotein fractions in rat arid Mongolian gerbil serum. Clin Chem. 39:1993;1861-1867.
21. Jessup W., Rankin S.M., De Whalley C., Hoult R.S., Scott J., Leake D.S. Alphatocopherol consumption during low density lipoprotein oxidation. Biochem J. 265:1990;399-405.
22. Hoff H.F., O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoproteins share a lability for aggregation, leading to enchanced macrophage degradation. Arteriosclerosis and Thrombosis. 11:1991;1209-1222.
23. Jiang Z. Y., Hunt J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Analyt Biochem. 202:1992;384-389.
24. Lane D.M., McConathy W.J., Laughlin L.O., Comp P.C., von Albertini B., Gibson S.M., Bricker L.A., Kozlovskis P., Dorrier C. Weekly treatment of diet/drug-resistant hypercholesterolemia with hepari n-induced extracorporeal low-density lipoprotein precipitation (HELP) system be selective plasma low-density lipoprotein removal. Am J Card. 71:1993;816-822.
25. Shacter E., Williams J.A., Lim M., Levine R.L. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Rad Biol Med. 17:1994;429-437.
26. Olinescu R., Nita S., Popovici D., Hertoghe J. The antioxidative action of fibrinogen and the implications of the effect on platelet aggregation. Rev Roum Med Int. 32:1994;185-193.